Bizarre Patents
Method and apparatus for making a drink hop along a bar or counter
A method for generating a drink which appears to hop from a remote spot on the bar or counter and take one or more leaps, before landing in a patron's glass.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8158665 | Farnesoid X receptor agonists The present invention provides novel substituted isoxazole compounds, pharmaceutical compositions, therapeutic uses and processes for preparing the same. ... | 04/17/2012 |
| 8097626 | IL-8 receptor antagonists This invention relates to novel compounds and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (Il-8). ... | 01/17/2012 |
| 8071592 | Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones Bicyclic nitrogen containing compounds and their use as antibacterials. ... | 12/06/2011 |
| 8063078 | Urea-compounds active as vanilloid receptor antagonists for the treatment of pain Certain compounds of formula (I), or a pharmaceutically acceptable salt thereof, or a solvate thereof, wherein R1, R2, P, P′, n, p, q, r and s are as defined in the specification, a process for prepa... | 11/22/2011 |
| 8044075 | IL-8 receptor antagonists This invention relates to novel compounds, compositions and combinations thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8). ... | 10/25/2011 |
| 7884098 | Anthranilamide inhibitors of aurora kinase The present invention relates to a compound represented by the following formula: or a pharmaceutically acceptable salt thereof; wherein R1, R1′ R2, R | 02/08/2011 |
| 7816395 | Pyrrolidinone anilines as progesterone receptor modulators The present invention relates to a compound represented by the following formula: or a pharmaceutically acceptable salt thereof, or a solvate thereof, or a combination thereof, wherein R1, R2, and X ar... | 10/19/2010 |
| 7786127 | Benzimidazole thiophene compounds The present invention provides benzimidazole thiophene compounds, pharmaceutical compositions containing the same, and their use as pharmaceutical agents. ... | 08/31/2010 |
| 7767682 | Medicaments Methods of prevention or treatment of renal diseases or conditions associated with abnormal ion flux, in particular autosomal dominant polycystic kidney disease, with a modulator of human peroxisome proliferator activated receptor gamma. ... | 08/03/2010 |
| 7709677 | Process of preparing arylethanoldiamines An improved process for preparing arylethanoldiamines is described. Compounds of this type are known to be useful as agonists at atypical beta-adrenoceptors (also known as beta-3-adrenoceptors). ... | 05/04/2010 |
| 7629340 | N-(6-membered aromatic ring)-amido anti-viral compounds Disclosed are compounds having Formula (I) and the compositions and methods relating to these compounds, for treating or preventing a viral infection mediated at least in part by a virus in the Flaviviridae family of viruses, wherein A, R2, m, R, V, W, T,... | 12/08/2009 |
| 7615643 | Benzimidazole thiophene compounds The present invention provides benzimidazole thiophene compounds pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents. ... | 11/10/2009 |
| 7595330 | Benzimidazole thiophene compounds The present invention provides benzimidazole thiophene compounds pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents. ... | 09/29/2009 |
| 7449468 | Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors The present invention provides a compound of formula (I): wherein R1-R5, R25, R26, Y, y, and X2are as defined herein. The compounds activate hu... | 11/11/2008 |
| 7439259 | Thiazole derivatives for treating PPAR related disorders The present invention provides combinations of compounds of formula (I) and other therapeutic agents for the treatment of PPAR related diseases. ... | 10/21/2008 |
| 6884801 | Imidazoline derivatives as alpha-1A adrenoceptor ligands Compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof are disclosed. Such compounds are useful in the treatment of Alpha-1A mediated diseases or conditions such as urinary incontinence. ... | 04/26/2005 |
| 6867225 | Thiazole or oxazole derivatives which are useful in the treatment of cardiovascular and related diseases A compound of formula (I) and pharmaceutically acceptable salts, solvates and hydrolysable esters thereof Wherein R1 and R2 are independently H or C1-3 alkyl or R1 | 03/15/2005 |
| 6787651 | Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agents Disclosed are substituted indoles, pharmaceutical compositions containing such indoles, and their use in treating or preventing PPAR-γ mediated diseases or conditions, such as osteopenia, osteoporosis, cancer, diabetes and atherosclerosis. ... | 09/07/2004 |
| 6723740 | Activator of PPAR delta Compounds of Formula (I) are disclosed. These compounds selected activators of human PPAR delta. ... | 04/20/2004 |
| 6710063 | Activators of PPAR delta Compounds of Formula (1) are disclosed. These compounds include selective activators of human PPAR delta. ... | 03/23/2004 |
| 6541492 | Thiazole derivatives as PPAR gamma ligands The present invention discloses novel PPAR gamma ligands of Formula (I) and pharmaceutically acceptable salts and solvates thereof. The present invention also discloses a method for treating osteoporosis by administration of a PPAR gamma antagonist.... | 04/01/2003 |
| 6518290 | Substituted oxazoles and thiazoles derivatives as HPPAr alpha activators A compound of formula (I) and pharmaceutically acceptable salts, solvates and hydrolysable esters thereof ##STR1## wherein; X1 represents O or S; R1 and R2 independently represent H, halogen, --CH3 and --OCH | 02/11/2003 |
| 6506781 | Oxazole PPAR antagonist A method is disclosed for rational design of a PPAR, FXR, LXR-alpha, or LXR-beta antagonist comprising chemical modification of a PPAR, FXR, LXR-alpha, or LXR-beta agonist to: a) prevent formation of a hydrogen bond between the agonist and tyrosine or his... | 01/14/2003 |
| 6498174 | Substituted oxazoles and thiazoles derivatives as hPPARγ and hPPAR activators The present invention discloses compounds of formula (I), and tautomeric forms, pharmaceutically acceptable salts, or solvates thereof. Preferably, the compounds of the invention are dual activators of hPPARγ and hPPAR.... | 12/24/2002 |
| 6306854 | Chemical compounds Novel compounds of Formula (1) and esters, salts, and physiologically functional derivatives thereof are disclosed. Methods for preparing and using the compounds are also disclosed. Many of these compounds are selective activators of PPAR alpha. The compo... | 10/23/2001 |
| 6251925 | Therapeutic biaryl derivatives The present invention relates to therapeutic biaryl derivatives of formula (I), and pharmaceutically acceptable derivatives thereof ##STR1## wherein R1 is a phenyl, naphthyl, pyridyl, thiazolyl, phenoxymethyl, or pyrimidyl group, optionally sub... | 06/26/2001 |
| 6096885 | Oxoazepine derivatives This invention relates to novel oxoazepine derivatives of Formula (I), R1 R2 NCOCH2 N(R3)COR4 (I) to processes for their preparation, to pharmaceutical compositions containing them and to their use i... | 08/01/2000 |
| 6090825 | Oxazole derivatives as antagonists of alpha 1C andrenergic receptors Oxazole compounds having formula (I) wherein R1 and R3 are selected from the group consisting of hydrogen, hydroxy, C1-6 alkyl, C1-6 alkoxy, C1-6 alkoxyC1-6 alkyl, phenyl or phenyl mono- or... | 07/18/2000 |
| 6048872 | Arylethanolamine derivatives and their use as agonists of atypical beta-adrenoceptors The present invention relates to phenethanolamine derivatives of formula (I) wherein R1 represents an aryl group optionally substituted by one or more substituents selected from halogen, hydroxy, C1-6 -alkoxy, C1-6 -alkyl,... | 04/11/2000 |
| 6040322 | Medicaments for ameliorating endothelial cell activation The use of compound of formula (I) in which: R1 and R2 are the same or different and each represents a hydrogen atom or a C1 -C5 alkyl group; R3 represents a hydrogen atom, a C1 -C6 | 03/21/2000 |
| 6028109 | Use of agonists of the peroxisome proliferator activated receptor alpha for treating obesity The use of agonists of the peroxisome proliferator activated receptor alpha (PPAR) for the manufacture of a medicament for the treatment of obesity and methods of treating obesity comprising the administration of a therapeutic amount of a PPAR ... | 02/22/2000 |
| 5998427 | Androstenones The present invention relates to compounds of formula (I), wherein carbons 1 and 2 are joined by either a single or a double bond; R1 is hydrogen or methyl; R2 is hydrogen or methyl; R3 is (B) wherein X, R6, R | 12/07/1999 |
| 5994554 | Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma The present invention provides radiolabeled 5-{4-[2-(Methyl-pyridine-2-yl-amino)-ethoxy]-benzyl}-thiazolidine-2,4-dion e. In another aspect, the present invention provides a method for determining whether a compound does or does not interact directly with ... | 11/30/1999 |
| 5977126 | Androstenones The present invention relates to methods for preparing and using compounds of formula (I), wherein carbons 1 and 2 are joined by either a single or a double bond; R1 is hydrogen or methyl; R2 is hydrogen or methyl; R3 is (... | 11/02/1999 |
| 5902726 | Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma The present invention provides activator compounds, including agonists, to the peroxisome proliferator-activated receptor gamma. Particular PPARγ activators are set forth, as are a pharmaceutical composition for treating diabetes, non-insulin-dependent d... | 05/11/1999 |
| 5846976 | Androstenone derivative The present invention relates to the compound of formula (I), ##STR1## also known as 17ଲ-N-(2,5-bis(Trifluoromethyl))phenylcarbamoyl-4-aza-5-andros t-1-en-3-one, solvates thereof, its preparation, intermediates used in its preparatio... | 12/08/1998 |
| 5817818 | Androstenones The present invention relates to compounds of formula (I), wherein carbons 1 and 2 are joined by either a single or a double bond; R1 is hydrogen or methyl; R2 is hydrogen or methyl; R3 is (A) or (B) wherein X, W, Z, R | 10/06/1998 |
| 5780464 | Enteric coated compositions of 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity A pharmaceutical formulation in solid dosage form for oral administration which comprises a compound of the general Formula (I) ##STR1## or a physiologically acceptable salt or solvate thereof together with one or more pharmaceutically acceptable car... | 07/14/1998 |
| 5739129 | CCK or gastrin modulating 5-heterocyclic-1, 5 benzodiazepines Compounds of general formula (I) and physiologically salts thereof, processes for their preparation and their use as modulators of the effects of gastrin and CCK.... | 04/14/1998 |
| 5708001 | Substituted 6-azaandrostenones The present invention relates to certain substituted 17ଲ-substituted carbonyl-6-azaandrost-4-en-3-ones of formula (I), wherein R1 and R2 i) are independently hydrogen or lower alkyl and the bond between the carbons bearing R | 01/13/1998 |
